While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
MMED is expected to report earnings to fall 40.55% to 10 cents per share on November 24
Q4'26
Est.
$0.10
Q3'26
Missed
by $0.01
Q2'26
Missed
by $0.84
The last earnings report on September 01 showed earnings per share of 16 cents, missing the estimate of 17 cents. With 2.20M shares outstanding, the current market capitalization sits at 4.70B.